Five popular academic oncology centers spread across Europe and the U.S have set up the Cyberknife Robotic Radiosurgery System.
The hospitals that have installed the system are The Royal Marsden Hospital and The Barts Cancer Center in London; Penn Medicine in Philadelphia; Charite University in Berlin, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice BranchPoland.
The CyberKnife System has proven clinical evidence of being effective in treatment of lung and prostate cancer through least invasive procedures. By installing the CyberKnife these hospitals would offer their patients the option of going in for least invasive radio surgical system for treating tumors. Euan S. Thompson, the president of Accuray said that prestigious academic centers choosing CyberKnife reinstated its reputation as a premier system for radiosurgery. The heads of the Radiation Oncology at Charite said the reason for choosing CyberKnife was based on the clinical proof of its ability to treat a wide range of tumors present anywhere in the body. They added that such advanced capabilities were not provided by other technologies. They concluded by saying that by using CyberKnife they were able to provide customized treatment to their patients with the most advanced treatment method available in radiosurgery.